What is CCCC stock price today?

Visit our real-time dashboard for the current CCCC stock price and live market data.

Is CCCC stock going up or down today?

CCCC stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CCCC stock now?

The decision to buy CCCC depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CCCC a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CCCC based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CCCC stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CCCC is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CCCC's P/E ratio?

P/E ratio data for CCCC will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CCCC's market cap?

CCCC (C4 Therapeutics Inc) has a market capitalization of $0.43 billion, making it a small-cap stock.

What is CCCC's price to book ratio?

Price-to-book ratio for CCCC is available on our dashboard along with other valuation metrics.

Does CCCC pay dividends?

CCCC does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CCCC's dividend yield?

CCCC does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CCCC stock a good long-term investment?

CCCC's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CCCC's revenue growth rate?

Revenue growth data for CCCC is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CCCC are available on our dashboard with complete income statement analysis.

What are the risks of investing in CCCC?

Key risks for CCCC include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CCCC compare to its competitors?

Compare CCCC to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CCCC's performance and positioning.

What is CCCC's stock price target for 2026?

Visit our prediction page for AI-powered price targets for CCCC with bull, base, and bear case scenarios.

What do analysts say about CCCC?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CCCC. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CCCC's next earnings report?

CCCC reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CCCC - C4 Therapeutics Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About C4 Therapeutics Inc

C4 Therapeutics Inc (CCCC) common stock

Price Chart

Loading chart...

CCCC Key Statistics

Market Cap

$425.68M

How CCCC Compares to Peers

CCCC is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
CCCC(This stock)	$425.68M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 17, 2026 at 2:03 PM EDT

Ready to invest in CCCC?

Commission-free trading available. Affiliate links.

CCCC Lician Score

10% confidence

5.0/10

Neutral

CCCC has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates CCCCacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

CCCC Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

5.0

Value

Valuation vs. sector peers

3.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for CCCC

Dashboard

Enter a ticker to analyze